Searching. Please wait…
1580
37
170
29264
4420
2603
347
391
Abstract: Introduction: The achievement of a state of tolerance and minimization of the immunosuppressive load form part of the ?Holy Grail? in solid organ transplantation. Galectin-1 recently has been described to be involved in the maintenance of a tolerant environment, but there is no evidence of its role in human liver transplantation. The aim of our study was to measure the serum levels of galectin-1 in stable liver transplant recipients. Methods: Serum levels of galectin-1 were determined in 30 stable liver transplant recipients who had been free of rejection episodes for at least 8 years. Fifteen patients with an acute rejection episode and 34 healthy subjects were used as the control group. Results: The concentrations of galectin-1 were significantly higher in stable liver transplant recipients compared with healthy subjects and with the acute rejection group. Conclusions: These preliminary results indicate that galectin-1 is upregulated in stable liver transplant recipients. Thus, our results extend the recent findings that galectin-1 may play an immune-suppressive role in liver transplantation. It remains to be established whether it might help to induce tolerance in liver transplantation.
Congress: Sociedad Española de Trasplante. Congreso (SET) (3º : 2014 : Valencia)
Publisher: Elsevier
Year of publication: 2015
No. of pages: 4
Publication type: Conference object
DOI: 10.1016/j.transproceed.2014.12.001
ISSN: 0041-1345,1873-2623
Read publication
GARCÍA, M.J.
JURADO, F.
DAVID SAN SEGUNDO ARRIBAS
MARCOS LOPEZ HOYOS
IRUZUBIETA, P.
LLERENA, S.
FERNANDO CASAFONT MORENCOS
MANUEL ANTONIO ARIAS RODRIGUEZ
PUENTE, Á.
JAVIER CRESPO GARCIA
EMILIO FABREGA GARCIA
Back